Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2007

View Archived Issues

New compounds for respiratory disorders claimed in recent patent literature

Monarsen improves myasthenia gravis status

Cognitive function not worsened in children with behavior disorders given risperidone

YM-150 effective and safe as venous thromboembolism prophylaxis

Axcan Pharma announces third quarter 2007 results

New antiinfective compounds described in recent patent literature

Antigenics reports second quarter 2007 results

PTC Therapeutics patents disclose novel compounds for HCV infections

Positive results for Antisoma's ASA-404 in phase II lung cancer trial

Newron and Merck report preliminary results of safinamide phase III trial for PD

Alpharma and Institut Biochimique sign NSAID patch marketing agreement

FDA grants orphan drug designation to Pharmion and MethylGene's MGCD-0103

Abraxis BioScience and TRSI enter epothilone licensing agreement for cancer

Genta begins phase III trial of Genasense for advanced melanoma

Interim data from phase II trial of HIV vaccine tgAAC-09 reported by Targeted Genetics

Daiichi Sankyo and Forest to copromote antihypertensive drug Azor

Eisai receives approval for additional efficacy and dosage for Aricept in Japan

SARMs designed at BMS with selectivity for muscle over prostate

Promising 11beta.-HSD1 inhibitor with potential in endocrine and metabolic disorders

Potential migraine therapeutics in development at Merck

Fast track designation for Marqibo in treatment of relapsed ALL

AstraZeneca profiles series of dual CXCR2/CCR2B antagonists for inflammation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...